Skip To Content
JEWISH. INDEPENDENT. NONPROFIT.
Make a matched gift and support Jewish journalism. DONATE NOW
Life

A Lifeline for Jewish Women With Ovarian Cancer

The genetic mutations that greatly increase a woman’s chance of getting breast cancer — mutations that are common among Ashkenazi Jewish women — also put her at high risk for ovarian cancer. So it makes sense that Sharsheret, which, since 2001, has been offering free support services to young Jewish women living with (or at high risk for) breast cancer, will be expanding to provide for women with ovarian cancer and those predisposed to the disease.

“We’ve found that women [with breast cancer] who are in our program, and women who are thinking about genetic testing, also have ovarian cancer on their minds,” Elana Silber, Sharsheret’s director of operations, told The Sisterhood.

Sharsheret is targeted at Jewish women in their 20s, 30s, and 40s. The organization offers confidential genetic counseling, peer support groups, health information, and seminars on topics such as parenting young children while undergoing cancer treatment. Within the next year, these services will made available to women suffering from or at risk for ovarian cancer, Silber said.

This is a moment of great uncertainty. Here’s what you can do about it.

We hope you appreciated this article. Before you go, we’d like to ask you to please support the Forward’s independent Jewish news. All donations are still being matched by the Forward Board - up to $100,000 until April 24.

This is a moment of great uncertainty for the news media, for the Jewish people, and for our sacred democracy. It is a time of confusion and declining trust in public institutions. An era in which we need humans to report facts, conduct investigations that hold power to account, tell stories that matter and share honest discourse on all that divides us.

With no paywall or subscriptions, the Forward is entirely supported by readers like you. Every dollar you give is invested in the future of the Forward — and telling the American Jewish story fully and fairly.

The Forward doesn’t rely on funding from institutions like governments or your local Jewish federation. There are thousands of readers like you who give us $18 or $36 or $100 each month or year.

Support our mission to tell the Jewish story fully and fairly.

Republish This Story

Please read before republishing

We’re happy to make this story available to republish for free, unless it originated with JTA, Haaretz or another publication (as indicated on the article) and as long as you follow our guidelines.
You must comply with the following:

  • Credit the Forward
  • Retain our pixel
  • Preserve our canonical link in Google search
  • Add a noindex tag in Google search

See our full guidelines for more information, and this guide for detail about canonical URLs.

To republish, copy the HTML by clicking on the yellow button to the right; it includes our tracking pixel, all paragraph styles and hyperlinks, the author byline and credit to the Forward. It does not include images; to avoid copyright violations, you must add them manually, following our guidelines. Please email us at [email protected], subject line “republish,” with any questions or to let us know what stories you’re picking up.

We don't support Internet Explorer

Please use Chrome, Safari, Firefox, or Edge to view this site.